GLP-1 TV · News & media
Patients in liver failure after using knock-off weight loss drug | ABC NEWS
Today’s cheapest GLP-1$39/mo at Wellmedr, sale price.Compare all GLP-1 prices Price read 22 Nov 2026 from the seller’s own page, ranked by price alone. That price is a compounded drug, and compounded drugs are not FDA-approved. Not from the video’s creator.Our summary
This ABC News Australia report follows Megan another speaker, a 32-year-old who became seriously ill after injecting a peptide she bought from a beautician to lose a few kilos. According to the report, she developed hair loss, skin sores and swelling while her body works to repair her liver. She says she now only leaves home for doctor's appointments, and that she had a constant run of nausea and vomiting in the weeks after injecting. She spent a month in hospital, where doctors considered her for a liver transplant.
Published by ABC News (Australia) on YouTube
As published by the channel. Not medical advice, and not an endorsement.
What else the video covers
The report says the product she believed she was buying was retatrutide, described as a new weight-loss drug similar to Ozempic that is still in development. It notes that retatrutide is being promoted on social media as the fastest new way to lose fat. One doctor says patients now email asking to be switched to a "better" medication they have heard about on TikTok, and that "peptide" is the current buzzword.
Doctors told the ABC they are alarmed by a rise in patients with serious organ damage after taking drugs sold as retatrutide. The report states that because retatrutide is not yet available for commercial use, products sold under that name are knock-offs that could be deadly. A doctor speaking in the piece says nobody knows what contaminants may be inside or how the product was made, and that they fear more life-threatening injuries if this continues. Another speaker says she is focused on recovery and urges others to use proper channels rather than shortcuts, which she says end up taking longer.
Our summary of what is said, in our words. Doses, results and prices are the speaker’s, not advice.
Takeaways
The main points, in the order they come up. Tap a time to play from there.
- 0:01 Megan another speaker, 32, now stays home with hair loss, skin sores and swelling as her body works to repair her liver.
- 0:31 She fell seriously ill within weeks of injecting a peptide from a beautician and spent a month in hospital, where a liver transplant was considered.
- 0:42 The report says she thought she was buying retatrutide, a still-in-development drug similar to Ozempic.
- 1:02 A doctor says patients are asking about peptides they have seen on TikTok, and retatrutide is promoted online as the fastest way to lose fat.
- 1:12 Doctors told the ABC they are seeing more patients with serious organ damage after taking products sold as retatrutide, which are knock-offs because the drug is not yet commercially available.
- 2:02 Another speaker advises people to go through the right places instead of taking shortcuts.
What the video says
As stated in the video, not checked by us. Doses and results are the speaker’s, not advice.
- Medication
- retatrutide
Questions this video answers
Is retatrutide available to buy legally?
According to the video, retatrutide is not yet available for commercial use and is still in development. The report says that any product sold as retatrutide is therefore a knock-off.
What happened to the woman who injected knock-off retatrutide?
The report says Megan another speaker became seriously ill within weeks, with nausea, vomiting, hair loss, skin sores and swelling as her body tries to repair her liver. She spent a month in hospital, where doctors considered a liver transplant.
Why do doctors say knock-off weight loss peptides are risky?
A doctor in the video says no one knows what contaminants may be inside or how the product was made. Doctors told the ABC they are alarmed by a rise in patients with serious organ damage after using drugs sold as retatrutide.
Videos on the same question
The closest videos in the library by what is said in them, not by title.
Clinical Trial: Retatrutide Side Effects & Weight Loss JourneyA woman enrolled in a retatrutide clinical trial describes her experience in conversation with a host.- What a GLP-1 costs at every program we trackToday’s lowest is $39/mo. Every program ranked by price alone. Compounded drugs are not FDA-approved.
Stopped Ozempic, Gained all the Weight Back...This is a reaction video.
Safety concerns over doctors prescribing experimental weight loss drug not approved by FDAAccording to this segment, a CBS News investigation found that doctors and other providers are offering an experimental weight loss drug called Retatide online, even though it is still in clinical trials and has not been approved by the FDA.
Doctors caught promoting unregulated weight-loss drug retatrutide, CBS News findsAccording to the video, the channel investigation looked at retatrutide, an injectable drug that is popular online under the nickname "Retatide" and is described as promising to curb hunger, shed fat and retain muscle.
Read next
Our guides closest to what this video covers, with prices checked weekly.
- Retatrutide: FDA status, trial results and when it could be approved
Retatrutide is not FDA-approved: Eli Lilly plans to submit it in Q1 2027, and FDA says it cannot be compounded. The weekly triple agonist (GIP, GLP-1 and glucagon) produced 28.3% weight loss at 80 weeks in TRIUMPH-1 on Lilly's efficacy measure (25.0% counting everyone randomized), and in October 2026 it beat Ozempic 2 mg head to head. Online "research" vials are illegal. Tirzepatide is the closest legal option, compounded from $69 a month on our board.
- GLP-1s for fatty liver disease (MASH): what Wegovy and tirzepatide do for the liver
Wegovy injection is the one GLP-1 approved to treat fatty liver disease: noncirrhotic MASH with stage F2 to F3 scarring in adults, under accelerated approval. In its trial, steatohepatitis resolved in 63% of patients on Wegovy against 34% on placebo after 72 weeks, and scarring improved in 37% against 22%. Tirzepatide cleared MASH in up to 62% in a 190-person phase 2 trial, but Zepbound and Mounjaro carry no liver indication. Ozempic does not either.
- Ozempic side effects, and the ones that actually make people stop
The common Ozempic side effects are gastrointestinal: nausea, vomiting, diarrhoea and constipation. They cluster in the first weeks and after each dose increase, which is why the drug is titrated slowly rather than started at the dose that does the work. Ozempic also carries a boxed warning for thyroid C-cell tumour risk, and the label for Wegovy, the same molecule, advises against combining it with another GLP-1. The practical thing nobody tells you: most people who quit do it during titration, and what decides whether that costs them money is the seller's pause and refund terms, not the sticker price.
Find more like it
Up next
More from this collection
Watched it? See what it costs.
Every GLP-1 program we track, ranked by what actually leaves your account.




















